Szewc, M.; Radzikowska-Bűchner, E.; Wdowiak, P.; Kozak, J.; Kuszta, P.; Niezabitowska, E.; Matysiak, J.; Kubiński, K.; Masłyk, M.
MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives. Int. J. Mol. Sci. 2022, 23, 2745.
https://doi.org/10.3390/ijms23052745
AMA Style
Szewc M, Radzikowska-Bűchner E, Wdowiak P, Kozak J, Kuszta P, Niezabitowska E, Matysiak J, Kubiński K, Masłyk M.
MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives. International Journal of Molecular Sciences. 2022; 23(5):2745.
https://doi.org/10.3390/ijms23052745
Chicago/Turabian Style
Szewc, Monika, Elżbieta Radzikowska-Bűchner, Paulina Wdowiak, Joanna Kozak, Piotr Kuszta, Ewa Niezabitowska, Joanna Matysiak, Konrad Kubiński, and Maciej Masłyk.
2022. "MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives" International Journal of Molecular Sciences 23, no. 5: 2745.
https://doi.org/10.3390/ijms23052745
APA Style
Szewc, M., Radzikowska-Bűchner, E., Wdowiak, P., Kozak, J., Kuszta, P., Niezabitowska, E., Matysiak, J., Kubiński, K., & Masłyk, M.
(2022). MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives. International Journal of Molecular Sciences, 23(5), 2745.
https://doi.org/10.3390/ijms23052745
